Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

Florian Lordick(Leipzig University of Applied Sciences), Yoon‐Koo Kang(Asan Medical Center), Hyun Cheol Chung(Yonsei University), Pamela Salman(Fundación Arturo López Pérez), Sang Cheul Oh(Korea University Medical Center), G. Bodoky(Unified Szent István and Szent László Hospital), G. Kurteva(University Specialized Hospital for Active Treatment of Endocrinology), Constantin Volovăț(Institutul Regional de Oncologie), Vladimir Moiseyenko(Institute of Oncology NN Petrov), В. А. Горбунова(Russian Cancer Research Center NN Blokhin), Joon Oh Park(Samsung Medical Center), Akira Sawaki(Aichi Cancer Center), Ilhan Celik(Merck (Germany)), Heiko Götte(Merck (Germany)), Helena Melezínková(Merck (Germany)), Markus Moehler(University Medical Center of the Johannes Gutenberg University Mainz)
The Lancet Oncology
April 17, 2013
Cited by 838Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis